Cigna Group Faces Sector Challenges Amid Rising Costs and Mixed Market Signals
Cigna Group navigates rising medical costs, specialty drug expenses, and mixed trading signals as analysts maintain a positive outlook amid sector-wide challenges.
Cigna Group navigates rising medical costs, specialty drug expenses, and mixed trading signals as analysts maintain a positive outlook amid sector-wide challenges.
F&G Annuities & Life topped insider buying among Q1 2025 mid-cap stocks, showing strong earnings turnaround and signaling confidence amid market volatility.